Kidney Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Targeted Combination Therapy for Advanced Solid Tumors
(Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.
- Treating Kidney Tumors in Patients With Von Hippel-Lindau Disease
(Posted: 02/15/2005) - In this phase II trial, researchers are investigating whether treatment with the drug 17AAG can effectively shrink kidney tumors in patients with von Hippel-Lindau disease.
- Study of Kidney Cancer Genetics in Ashkenazi Jewish Families
(Posted: 02/24/2004) - In this study, researchers will analyze blood and tissue samples from persons with suspected or confirmed inherited kidney cancer. Researchers are especially interested in enrolling Ashkenazi Jews from families that have at least two members with this disease.
- Study of Antiangiogenic Therapy for Kidney Cancer
(Posted: 02/03/2004) - This trial will compare the effectiveness of interferon alfa-2b plus bevacizumab versus interferon alfa-2b alone in treating patients who have advanced renal cell carcinoma.